Company profile

Antidote

Where patients meet research — accelerating clinical trials through precision recruitment

Clinical Trials & Research

Company profile

About Antidote

Antidote Technologies is a precision recruitment company on a mission to catalyze medical innovation by successfully connecting patients and researchers. The company addresses a critical problem in medical research: more than 80% of clinical studies are delayed due to lack of participants. Antidote solves this through two complementary approaches. For pharmaceutical sponsors and life science companies, they provide precision recruitment services using digital marketing, AI-powered patient matching, and a network of 300+ healthcare partners to accelerate enrollment. For patients, they've built the Match search engine—a smart platform that makes finding relevant clinical trials easy and accessible. The company brings together professionals with pharmaceutical, technology, business, and public health backgrounds to achieve their mission. Antidote operates with a patient-first mindset and maintains strong commitments to diversity, equity, and inclusion in clinical trial populations, as well as environmental, social, and corporate governance. They've received the Silver Award from Ecovadis for two consecutive years, placing them in the top 25% of companies assessed for corporate social responsibility. Through partnerships with organizations like JDRF, MSAA, BrightFocus Foundation, Beyond Type 1, and Melanoma Research Alliance, Antidote provides dynamic content and trial search tools to patient communities while helping researchers find the volunteers they need for breakthrough treatments.

Company description Antidote official website

Mission. Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies.

Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Antidote?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cardiometabolic conditions
  • Hypertension
  • Lung Cancer
  • Melanoma
  • Multiple Sclerosis
  • Obesity
  • Type 1 Diabetes

Who it serves

  • Clinical research organizations
  • Health nonprofits
  • Life science companies
  • Patient advocacy groups
  • Pharmaceutical companies

Deployment & integration

Cloud Saas deployment with recorded integration context.

Recorded integration context: SEQSTER.

Geographic context

MarketsEuropean Union · United States
Company sourceOfficial website

Company milestones

Platform expansion

Partnership with SEQSTER announced in 2024 for patient matching and real-time data access. Launched first-ever Spanish-language clinical trial search engine for type 1 diabetes with Beyond Type 1 and JDRF. Received Ecovadis Silver Award for two consecutive years (2022, 2023).

Partnerships

Recorded partners

  • Beyond Type 1
  • BrightFocus Foundation
  • JDRF
  • Melanoma Research Alliance
  • MSAA (Multiple Sclerosis Association of America)
  • SEQSTER

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Antidote Match

Smart search engine connecting patients with clinical trials

Platform · Cloud SaaSCompany source

Enterprise Match

Precision recruitment services for clinical trial sponsors

Service · Cloud SaaSCompany source

Market Feasibility

Real-world insights testing patient reach and qualification before study launch

Service · Cloud SaaSCompany source

Media Capabilities

Digital marketing and patient engagement campaigns for clinical trials

Service · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

80% of medical research delayed due to lack of participants

Problem statement Antidote addresses

300+ healthcare partners

Partner network for patient reach

Top 25% of 90,000 companies

Ecovadis Silver Award for CSR commitment

Beyond Type 1

Launching Spanish-language clinical trial search for type 1 diabetes patients

First-ever Spanish-language T1D clinical trial search engine launched

BrightFocus Foundation

Providing families with clear, reliable information on clinical trials and accelerating path to new treatments

Recognized as tremendous resource for connecting families with clinical trial information

JDRF (Juvenile Diabetes Research Foundation)

Helping researchers find volunteers for type 1 diabetes trials and connecting T1D community with research opportunities

Launched first-ever Spanish-language clinical trial search engine for type 1 diabetes

Melanoma Research Alliance

Enhancing clinical trial search capabilities for people impacted by melanoma

Successfully partnered to improve trial access for melanoma patients

Multiple Sclerosis Association of America (MSAA)

Providing MS community access to clinical trial matching and resources to expedite MS research

Successfully integrated Antidote Match search tool to connect MS patients with appropriate clinical trials

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Antidote

Recent articles published on Antidote's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Clinical Trials & Research

Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon